Value of 4D MR Angiography at 3T Compared with DSA for the Follow-Up of Treated Brain Arteriovenous Malformation

REFERENCES

1. 1.↵
   1. Forsting M

   2. Cognard C,
   3. Spelle L,
   4. Pierot L

   . Pial arteriovenous malformations. In: Forsting M, ed. Intracranial Malformations and Aneurysms. Berlin/New York: Springer-Verlag; 2004:39–100
2. 2.↵
   2. Choi JH,
   3. Mohr JP

   . Brain arteriovenous malformations in adults. Lancet Neurol 2005;4:299–308

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Da Costa L,
   3. Wallace MC,
   4. Ter Brugge KG, et al

   . The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 2009;40:100–05

   Abstract/FREE Full Text
4. 4.↵
   2. Kondziolka D,
   3. McLaughlin MR,
   4. Kestle JR

   . Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery 1995;37:851–55

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Pierot L,
   3. Cognard C,
   4. Spelle L

   . Cerebral arteriovenous malformations: evaluation of the hemorrhagic risk and its morbidity. J Neuroradiol 2004;31:369–75

   CrossRefPubMed
6. 6.↵
   2. Novakovic RL,
   3. Lazzaro MA,
   4. Castonguay AC, et al

   . The diagnosis and management of brain arteriovenous malformations. Neurol Clin 2013;31:749–63

   CrossRefPubMed
7. 7.↵
   2. Pierot L,
   3. Januel AC,
   4. Herbreteau D, et al

   . Endovascular treatment of brain arteriovenous malformations using Onyx: preliminary results of a prospective, multicenter study. Interventional Neuroradiology 2005;11(suppl 1):159–64

   PubMed
8. 8.↵
   2. Pierot L,
   3. Januel AC,
   4. Herbreteau D, et al

   . Endovascular treatment of brain arteriovenous malformations using Onyx: results of a prospective, multicenter study. J Neuroradiol 2009;36:147–52

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Pierot L,
   3. Cognard C,
   4. Herbreteau , et al

   . Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO). Eur Radiol 2013;23:2838–45

   CrossRefPubMed
10. 10.↵
    2. Pierot L,
    3. Kadziolka K,
    4. Litré F, et al

    . Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery. AJNR Am J Neuroradiol 2013;34:1395–400

    Abstract/FREE Full Text
11. 11.↵
    2. Kaufmann TJ,
    3. Huston J III.,
    4. Mandrekar JN, et al

    . Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 2007;243:812–19

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Fifi JT,
    3. Meyers PM,
    4. Lavine SD, et al

    . Complications of modern diagnostic cerebral angiography in an academic medical center. J Vasc Interv Radiol 2009;20:442–47

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Thiex R,
    3. Norbash AM,
    4. Frerichs KU

    . The safety of dedicated-team catheter-based diagnostic cerebral angiography in the era of advanced noninvasive imaging. AJNR Am J Neuroradiol 2010;31:230–34

    Abstract/FREE Full Text
14. 14.↵
    2. Heidenreich JO,
    3. Schilling AM,
    4. Unterharnscheidt F, et al

    . Assessment of 3D-TOF-MRA at 3.0 Tesla in the characterization of the angioarchitecture of cerebral arteriovenous malformations: a preliminary study. Acta Radiol 2007;48:678–86

    FREE Full Text
15. 15.↵
    2. Unlu E,
    3. Temizoz O,
    4. Albayram S, et al

    . Contrast-enhanced MR 3D angiography in the assessment of brain AVMs. Eur J Radiol 2006;60:367–78

    CrossRefPubMed
16. 16.↵
    2. Lee KE,
    3. Choi CG,
    4. Choi JW, et al

    . Detection of residual brain arteriovenous malformations after radiosurgery: diagnostic accuracy of contrast-enhanced three-dimensional time of flight MR angiography at 3.0 Tesla. Korean J Radiol 2009;10:333–39

    CrossRefPubMed
17. 17.↵
    2. Taschner CA,
    3. Gieseke J,
    4. Le Thuc V, et al

    . Intracranial arteriovenous malformation: time-resolved contrast-enhanced MR angiography with combination of parallel imaging, keyhole acquisition, and k-space sampling techniques at 1.5 T. Radiology 2008;246:871–79

    CrossRefPubMed
18. 18.↵
    2. Parmar H,
    3. Ivancevic MK,
    4. Dudek N, et al

    . Neuroradiologic applications of dynamic MR angiography at 3 T. Magn Reson Imaging Clin N Am 2009;17:63–75

    CrossRefPubMed
19. 19.↵
    2. Hadizadeh DR,
    3. von Falkenhausen M,
    4. Gieseke J, et al

    . Cerebral arteriovenous malformation: Spetzler-Martin classification at subsecond-temporal-resolution four-dimensional MR angiography compared with that at DSA. Radiology 2008;246:205–13

    CrossRefPubMed
20. 20.↵
    2. Machet A,
    3. Portefaix C,
    4. Kadziolka K, et al

    . Brain arteriovenous malformation diagnosis: value of time-resolved contrast-enhanced MR angiography at 3.0 T compared to DSA. Neuroradiology 2012;54:1099–108

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Hadizadeh DR,
    3. Kukuk GM,
    4. Steck DT, et al

    . Noninvasive evaluation of cerebral arteriovenous malformations by 4D-MRA for preoperative planning and postoperative follow-up in 56 patients: comparison with DSA and intraoperative findings. AJNR Am J Neuroradiol 2012;33:1095–101

    Abstract/FREE Full Text
22. 22.↵
    2. Lim HK,
    3. Choi CG,
    4. Kim SM, et al

    . Detection of residual brain arteriovenous malformations after radiosurgery: diagnostic accuracy of contrast-enhanced four-dimensional MR angiography at 3.0 T. Br J Radiol 2012;85:1064–69

    Abstract/FREE Full Text
23. 23.↵
    2. Weiger M,
    3. Pruessmann KP,
    4. Kassner A, et al

    . Contrast-enhanced 3D MRA using SENSE. J Magn Reson Imaging 2000;12:671–77

    CrossRefPubMed
24. 24.↵
    2. Willinek WA,
    3. Gieseke J,
    4. Conrad R, et al

    . Randomly segmented central k-space ordering in high-spatial-resolution contrast-enhanced MR angiography of the supraaortic arteries: initial experience. Radiology 2002;225:583–88

    CrossRefPubMed
25. 25.↵
    2. Steiner L,
    3. Lindquist C,
    4. Adler JR, et al

    . Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg 1992;77:1–8

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Maesawa S,
    3. Flickinger JC,
    4. Kondziolka D, et al

    . Repeated radiosurgery for incompletely obliterated arteriovenous malformations. J Neurosurg 2000;92:961–70

    CrossRefPubMed
27. 27.↵
    2. Khandanpour N,
    3. Griffiths P,
    4. Warren D, et al

    . Prospective comparison of late 3T MRI with conventional angiography in evaluating the patency of cerebral arteriovenous malformations treated with stereotactic radiosurgery. Neuroradiology 2013;55:683–87

    CrossRefPubMed
28. 28.↵
    2. Ansari SA,
    3. Schnell S,
    4. Carroll T, et al

    . Intracranial 4D flow MRI: toward individualized assessment of arteriovenous malformation hemodynamics and treatment-induced changes. AJNR Am J Neuroradiol 2013;34:1922–28

    Abstract/FREE Full Text
29. 29.↵
    2. Illies T,
    3. Forkert ND,
    4. Ries T, et al

    . Classification of cerebral arteriovenous malformations and intranidal flow patterns by color-encoded 4D-hybrid-MRA. AJNR Am J Neuroradiol 2013;34:46–53

    Abstract/FREE Full Text
30. 30.↵
    2. Kukuk GM,
    3. Hadizadeh DR,
    4. Boström A, et al

    . Cerebral arteriovenous malformations at 3.0 T: intraindividual comparative study of 4D-MRA in combination with selective arterial spin labeling and digital subtraction angiography. Invest Radiol 2010;45:126–32

    CrossRefPubMed
31. 31.↵
    2. Willinek WA,
    3. Hadizadeh DR,
    4. von Falkenhausen M, et al

    . 4D time-resolved MR angiography with keyhole (4D-TRAK): more than 60 times accelerated MRA using a combination of CENTRA, keyhole, and SENSE at 3.0 T. J Magn Reson Imaging 2008;27:1455–60

    CrossRefPubMedWeb of Science